H3K4 methyltransferase KMT2A (MLL1) expression increases in GBM in the setting of hypoxia in a HIF-dependent manner, with knockdown leading to decreased self-renewal in vitro and decreased tumor formation in vivo (168). This evidence concerns the gene KMT2A and glioblastoma.